Treatment Delays in Non-small Cell Lung Cancer and Their Prognostic Implications
- 1 July 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 6 (7), 1254-1259
- https://doi.org/10.1097/jto.0b013e318217b623
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung CancerJournal of Clinical Oncology, 2010
- Lung Cancer Diagnostic and Treatment Intervals in the United States: A Health Care Disparity?Journal of Thoracic Oncology, 2009
- Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non–Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical TrialsClinical Cancer Research, 2009
- Biological Prognostic and Predictive Factors in Lung CancerOncology, 2009
- Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patientsAnnals Of Oncology, 2008
- Diagnosis and Management of Lung Cancer Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)Chest, 2007
- A prognostic model for advanced stage nonsmall cell lung cancerCancer, 2006
- Private Health Care in CanadaNew England Journal of Medicine, 2006
- Épidémiologie et délais de prise en charge de 355 patients atteints de cancer bronchiqueRevue des Maladies Respiratoires, 2006
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004